ArticleClinical and translational medicine2025

SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.

Manuela Mancini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.